Shots: The US FDA has approved FT designation for Bemcentinib to treat elderly patients with acute myeloid leukemia (AML) whose disease has relapsed The FDA’s Fast Track designation facilitates the […]readmore
Tags : Relapsed Acute Myeloid Leukemia